ALPS Advisors »

Aardvark Therapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $235k 18k 13.13

More positions owned by ALPS Advisors

Western Midstream Partners L Com Unit Lp Int (WES)
Energy Transfer Com Ut Ltd Ptn (ET)
Enterprise Products Partners (EPD)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Usa Compression Partners Com Unit Ltdpar (USAC)
Genesis Energy Unit Ltd Partn (GEL)
Cameco Corporation (CCJ)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Global Partners Com Units (GLP)
Uranium Energy (UEC)
Delek Logistics Partners Com Unt Rp Int (DKL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for ALPS Advisors

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Millennium Management
Silverarc Capital Management
Geode Capital Management
State Street Corporation
Two Sigma Investments
Centiva Capital
Cantor Fitzgerald, L. P.
Northern Trust
Superstring Capital Management
Goldman Sachs Group

View all funds holding Aardvark Therapeutics